- $138.44bn
- $190.12bn
- $62.58bn
Brief: Chai Discovery Announces License Agreement With Pfizer To Accelerate Drug Discovery With AI
Celcuity rises after boosted $500 mln convertible bond offering
Celcuity drops further after announcing $400 mln convertible offering
Celcuity plunges after experimental breast cancer treatment data disappoints
Fulcrum plummets over 50% after scrapping lead sickle-cell drug on FDA concerns (updated)
Fulcrum plummets 50% after scrapping lead sickle-cell drug on FDA concerns
Brief: Pfizer Says Talzenna Plus Xtandi Improves Radiographic Progression-Free Survival By Over 50% In Metastatic Prostate Cancer
Brief: Pfizer Says EC Authorizes Update To Pediatric Use Of Pfizer & BioNTech Covid 19 Vaccine
Brief: Pfizer Says Lorbrena Shows 55% Likelihood Of Progression-Free Survival At 7 Years In NSCLC Trial
China's Innovent jump most in nearly a year on Pfizer cancer drug deal
Brief: Innovent Biologics Enters Global Strategic Collaboration With Pfizer For 12 Oncology Programs
Innovent Biologics, Pfizer strike $10.5 bln cancer drug deal amid China biotech boom (updated)
China's Innovent Biologics, Pfizer strike up to $10.5 billion cancer drug deal
Brief: Pfizer And Innovent Biologics Enter Global Strategic Collaboration To Accelerate Development Of Innovative Oncology Medicines
US FDA advisers vote in favor of recommending COVID vaccines target XFG variant
FDA advisers recommend COVID vaccines be updated to target current dominant variant (updated)
Cogent rises as US FDA accepts marketing application for cancer drug
FDA advisers to weigh composition of COVID vaccines for 2026-2027
Health Rounds: Veracyte genomic test identifies breast cancer patients who can skip chemo